KVD900

Sebetralstat · KalVista Pharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for KVD900, covering 2023-02-08 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Update: PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial [Phase 3]